Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Biomark Diagnostics Inc logo — Leading the world in early cancer detection research.

Biomark Diagnostics Inc

Leading the world in early cancer detection research.

Founded 2006 Canada Richmond, Canada 9 employees Total: $3.43M Biotechnology, Health Care

General Information

Company Name Biomark Diagnostics Inc
Founded Year 2006
Location Canada Richmond, Canada
Founders / Decision Makers
Team member
Employees 9
Industries Biotechnology, Health Care
Business Model B2B, B2B2C
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Biomark Diagnostics Inc. To contact Biomark Diagnostics Inc, visit biomarkdiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biomark Diagnostics Inc compare?

A PDF of Biomark Diagnostics Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biomark Diagnostics Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biomark Diagnostics Inc

Biomark Diagnostics Inc, founded in 2006 and headquartered in Canada, is leading the world in early cancer detection research. This biotechnology and healthcare company has developed advanced diagnostic technologies aimed at improving patient outcomes. They own multiple intellectual properties that focus on the detection and quantitation of metabolites.

Their dedicated team, a global consortium of scientists, engineers, and medical professionals, was formed in 2007 to commercialize their innovative technology. They are committed to enhancing the prediction and accuracy in cancer diagnoses while adhering to stringent regulatory, clinical, and scientific standards.

Biomark Diagnostics Inc recently secured a $290.00K grant investment on 09 April 2024, backed by Research Manitoba and Mitacs, underscoring investor confidence in their pioneering approach and growth potential in the oncology diagnostics space.

Business keywords: cancer detection, oncology diagnostics, metabolite detection, intellectual property, innovative technology, commercialization, clinical standards, scientific standards, enterprise team, patient outcomes, early cancer detection, medical professionals, biomarker technology, regulatory compliance

Services & Products

Early Stage Cancer Detection
Liquid Biopsy Technology
Metabolomics-based Diagnostics
AI-driven Cancer Analysis
Biomarker Identification

Target Customers

Oncologists Medical Professionals Healthcare Institutions Cancer Research Organizations Biotech Investors

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $290.00K 1
Mitacs
01 Apr 2024
Private Placement VC $1.90M -
01 Dec 2023
Private Placement VC $240.00K -
01 May 2022
Grant $170.00K 1
National Research Council Canada / Conseil national de recherches Canada
National Research Council Canada / Conseil national de recherches Canada
01 Nov 2021
Grant $830.00K 4
Health Venture MEDTEQ+ CANCER FUND
Health Venture, MEDTEQ+ +2
01 Jun 2021
IPO Undisclosed -
01 Nov 2014

Biomark Diagnostics Inc Alternatives & Competitors

View All Alternatives
Biomark Diagnostics Inc vs
bioAffinity Technologies
bioAffinity Technologies United States

Addressing a critical need to find cancer early and treat cancer at the cellular level.

Post-IPO Equity
22 employees
Biotechnology, Health Care
Biomark Diagnostics Inc vs
Cyted Health
Cyted Health United Kingdom

Transforming access to digestive health for everyone, everywhere.

Non Equity Assistance
74 employees
AI, Biotechnology
Biomark Diagnostics Inc vs
NovaScan
NovaScan United States

Easy to use ex vivo and in vivo cancer detection that provides instantaneous, highly accurate result...

Convertible Note
16 employees
Biotechnology, Health Care
View all alternatives

FAQ About Biomark Diagnostics Inc

Leading the world in early cancer detection research.
Biomark Diagnostics Inc was founded in 2006.
Biomark Diagnostics Inc is headquartered in Richmond, Canada.
Biomark Diagnostics Inc operates in Biotechnology and Health Care. Its work centres on cancer detection, oncology diagnostics, metabolite detection and intellectual property. Its customers include Oncologists, Medical Professionals and Healthcare Institutions.
Biomark Diagnostics Inc has a B2B and B2B2C business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Biomark Diagnostics Inc has approximately 9 employees.
Biomark Diagnostics Inc has completed 6 funding rounds, raising a total of $3.43M.
Biomark Diagnostics Inc offers: Early Stage Cancer Detection, Liquid Biopsy Technology, Metabolomics-based Diagnostics, AI-driven Cancer Analysis, Biomarker Identification.
Top alternatives and competitors to Biomark Diagnostics Inc include bioAffinity Technologies, Cyted Health, NovaScan, Genekor Medical S.A., Dxcover. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biomark Diagnostics Inc and bioAffinity Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biomark Diagnostics Inc, https://bouncewatch.com/company/biomark-diagnostics-inc, updated 27 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout